AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Schreij, G van der Geest, S Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals, J ACQ IMM D, 27(4), 2001, pp. 344-349
A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients
Authors: Ungsedhapand, C Kroon, EDMB Suwanagool, S Ruxrungtham, K Yimsuan, N Sonjai, A Ubolyam, S Buranapraditkun, S Tiengrim, S Pakker, N Kunanusont, C Lange, JMA Cooper, DA Phanuphak, P
Citation: C. Ungsedhapand et al., A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients, J ACQ IMM D, 27(2), 2001, pp. 116-123
A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy
Authors: Burger, DM Hugen, PWH Aarnoutse, RE Dieleman, JP Prins, JM van der Poll, T ten Veen, JH Mulder, JW Meenhorst, PL Blok, WL van der Meer, JTM Reiss, P Lange, JMA
Citation: Dm. Burger et al., A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy, J ACQ IMM D, 26(3), 2001, pp. 218-224
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
Authors: Foudraine, NA Jurriaans, S Weverling, GJ Burger, DM Hoetelmans, RMW Roos, MTL Maas, J Miedema, F Reiss, P Portegies, P de Wolf, F Lange, JMA
Citation: Na. Foudraine et al., Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial, ANTIVIR TH, 6(1), 2001, pp. 55-62
Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1
Authors: van Praag, RME van Heeswijk, RPG Jurriaans, S Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1, CLIN INF D, 33(8), 2001, pp. E91-E92
Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection
Authors: Enting, RH Prins, JM Jurriaans, S Brinkman, K Portegies, P Lange, JMA
Citation: Rh. Enting et al., Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection, CLIN INF D, 32(7), 2001, pp. 1095-1099
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion
Authors: Van Praag, RME Prins, JM Roos, MTL Schellekens, PTA Ten Berge, IJM Yong, SL Schuitemaker, H Eerenberg, AJM Jurriaans, S De Wolf, F Fox, CH Goudsmit, J Miedema, F Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
Authors: Veldkamp, AI Weverling, GJ Lange, JMA Montaner, JSG Reiss, P Cooper, DA Vella, S Hall, D Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals, AIDS, 15(9), 2001, pp. 1089-1095
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy
Authors: Kostense, S Raaphorst, FM Joling, J Notermans, DW Prins, JM Danner, SA Reiss, P Lange, JMA Teale, JM Miedema, F
Citation: S. Kostense et al., T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy, AIDS, 15(9), 2001, pp. 1097-1107
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways
Authors: van der Valk, M Bisschop, PH Romijn, JA Ackermans, MT Lange, JMA Endert, E Reiss, P Sauerwein, HP
Citation: M. Van Der Valk et al., Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways, AIDS, 15(16), 2001, pp. 2093-2100
Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection
Authors: Nieuwkerk, PT Gisolf, EH Reijers, MHE Lange, JMA Danner, SA Sprangers, MAG
Citation: Pt. Nieuwkerk et al., Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection, AIDS, 15(15), 2001, pp. 1985-1991
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine
Authors: Conway, B Wainberg, MA Hall, D Harris, M Reiss, P Cooper, D Vella, S Curry, R Robinson, P Lange, JMA Montaner, JSG
Citation: B. Conway et al., Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine, AIDS, 15(10), 2001, pp. 1269-1274
The ADAM study continued: maintenance therapy after 50 weeks of induction therapy
Authors: Reijers, MHE Weverling, GJ Jurriaans, S Roos, MTL Wit, FWNM Weigel, HM Ten Kate, RW Mulder, JW Richter, C Ter Hofstede, HJM Sprenger, H Hoetelmans, RMW Schuitemaker, H Lange, JMA
Citation: Mhe. Reijers et al., The ADAM study continued: maintenance therapy after 50 weeks of induction therapy, AIDS, 15(1), 2001, pp. 129-131
Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Hoetelmans, RMW Lange, JMA Beijnen, JH
Citation: Ai. Veldkamp et al., Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine, THER DRUG M, 23(6), 2001, pp. 606-611
Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Beijnen, JH Lange, JMA Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine, THER DRUG M, 23(3), 2001, pp. 255-258
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates
Authors: Rongkavilit, C Thaithumyanon, P Chuenyam, T Damle, BD Limpongsanurak, S Boonrod, C Srigritsanapol, A Hassink, EAM Hoetelmans, RMW Cooper, DA Lange, JMA Ruxrungtham, K Phanuphak, P
Citation: C. Rongkavilit et al., Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates, ANTIM AG CH, 45(12), 2001, pp. 3585-3590
Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma
Authors: van Praag, RME Repping, S de Vries, JWA Lange, JMA Hoetelmans, RMW Prins, JM
Citation: Rme. Van Praag et al., Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma, ANTIM AG CH, 45(10), 2001, pp. 2902-2907
The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons
Authors: Veldkamp, AI Harris, M Montaner, JSG Moyle, G Gazzard, B Youle, M Johnson, M Kwakkelstein, MO Carlier, H van Leeuwen, R Beijnen, JH Lange, JMA Reiss, P Hoetelmans, RMW
Citation: Ai. Veldkamp et al., The steady-state pharmacokinetics of efavirenz and nevirapine when used incombination in human immunodeficiency virus type 1-infected persons, J INFEC DIS, 184(1), 2001, pp. 37-42
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study
Authors: Nieuwkerk, PT Sprangers, MAG Burger, DM Hoetelmans, RMW Hugen, PWH Danner, SA van der Ende, ME Schneider, MME Schrey, G Meenhorst, PL Sprenger, HG Kauffmann, RH Jambroes, M Chesney, MA de Wolf, F Lange, JMA
Citation: Pt. Nieuwkerk et al., Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, ARCH IN MED, 161(16), 2001, pp. 1962-1968
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy
Authors: Gisolf, EH van Praag, RME Jurriaans, S Portegies, P Goudsmit, J Danner, SA Lange, JMA Prins, JM
Citation: Eh. Gisolf et al., Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy, J ACQ IMM D, 25(5), 2000, pp. 426-433
Dose-finding study of a once-daily indinavir/ritonavir regimen
Authors: Hugen, PWH Burger, DM ter Hofstede, HJM Koopmans, PP Stek, M Hekster, YA Reiss, P Lange, JMA
Citation: Pwh. Hugen et al., Dose-finding study of a once-daily indinavir/ritonavir regimen, J ACQ IMM D, 25(3), 2000, pp. 236-245
Nevirapine plus didanosine: Once or twice daily combination?
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Reiss, P Lange, JMA Kwakkelstein, MO Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Nevirapine plus didanosine: Once or twice daily combination?, J ACQ IMM D, 25(1), 2000, pp. 93-95
Antiviral therapy in 2000
Authors: Lange, JMA Richman, DD
Citation: Jma. Lange et Dd. Richman, Antiviral therapy in 2000, ANTIVIR TH, 5(1), 2000, pp. 1-1
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
Authors: Hazenberg, MD Otto, SA Stuart, JWTC Verschuren, MCM Borleffs, JCC Boucher, CAB Coutinho, RA Lange, JMA De Wit, TFR Tsegaye, A Van Dongen, JJM Hamann, D De Boer, RJ Miedema, F
Citation: Md. Hazenberg et al., Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection, NAT MED, 6(9), 2000, pp. 1036-1042
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations
Authors: Notermans, DW De Wolf, F Oudshoorn, P Cuijpers, HT Pirillo, M Tiller, FW McClernon, DR Prins, JM Lange, JMA Danner, SA Goudsmit, J Jurriaans, S
Citation: Dw. Notermans et al., Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations, AIDS RES H, 16(15), 2000, pp. 1507-1517
Risultati: 1-25 | 26-50 | 51-58